Generation of a CRISPR/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having &#945;-galactosidase (GLA) gene mutation (c.803_806del).

Choi, Jong Bin; Seo, Donghyuk; Do, Hyo-Sang; Han, Yong-Mahn

Generation of a CRISPR/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having α-galactosidase (GLA) gene mutation (c.803_806del).

Choi, Jong Bin; Seo, Donghyuk; Do, Hyo-Sang; Han, Yong-Mahn.

Affiliation

Choi JB; Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea.
Seo D; Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea.
Do HS; Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Han YM; Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea. Electronic address: ymhan57@kaist.ac.kr.

Stem Cell Res ; 66: 103001, 2023 02.

Article in En | MEDLINE | ID: mdl-36516658

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fabry Disease / Induced Pluripotent Stem Cells Limits: Humans Language: En Journal: Stem Cell Res Year: 2023 Document type: Article Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google